Mebeverinehydrochloride Aurobindo (Mebeverine Hydrochloride)

Mebeverine Hydrochloride acts as a direct smooth‑muscle relaxant in the gastrointestinal tract. It inhibits calcium entry into smooth‑muscle cells and modulates intracellular signaling, which diminishes hyper‑contractility and spasm while preserving normal peristalsis, thereby easing symptoms of functional bowel conditions.

The appropriate dose of Mebeverinehydrochloride Aurobindo is determined by the prescribing physician based on the individual’s condition, severity of symptoms, and overall health status. Patients should follow the exact dosing instructions provided by their healthcare professional and not adjust the dose on their own.

Safety data for Mebeverinehydrochloride Aurobindo in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Mebeverine differs from many anticholinergic antispasmodics because it relaxes smooth muscle without significantly affecting normal motility or causing strong anticholinergic side effects such as dry mouth or urinary retention. This profile often makes it a preferred option for patients who need spasm relief but wish to avoid pronounced anticholinergic burden.

Store the product at room temperature, preferably below 25 °C. Keep it in the original packaging to protect from moisture and light, and ensure the container is tightly closed to maintain product stability throughout its shelf life.

Mebeverinehydrochloride Aurobindo is taken orally, usually with a glass of water. It can be administered with or without food, but patients should follow the specific instructions given by their prescriber regarding timing relative to meals.

Serious risks, though rare, include allergic reactions such as rash, itching, or angioedema, as well as severe hypotension and cardiac arrhythmias. Patients should seek immediate medical attention if they experience any signs of an allergic response or unexplained cardiovascular symptoms.

Individuals with a known hypersensitivity to mebeverine or any of the tablet’s excipients should avoid the medication. Caution is also advised for patients with severe hepatic or renal impairment, and it should be used only under medical supervision in pregnant or breastfeeding women.